Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Danaher Corporation

DHRNYSE
Healthcare
Medical - Diagnostics & Research
$210.92
$1.42(0.68%)
U.S. Market opens in 15h 52m

Danaher Corporation (DHR) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap149.1B
P/E Ratio41.10
EPS (TTM)$5.03
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$205.71
3 Months$177.09
1 Year Target$222.74

DHR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Danaher Corporation (DHR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $222.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 41.10 and a market capitalization of 149.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.67%
5-Day Change
2.46%
1-Month Change
-10.25%
3-Month Change
-7.25%
6-Month Change
-0.42%
Year-to-Date (YTD) Change
-8.46%
1-Year Change
-0.11%
3-Year Change
-5.77%
5-Year Change
6.29%
All-Time (Max) Change
35304.81%

Contact Information

202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

610,000 Employees
IPO DateDec 29, 1978
CountryUS
Actively Trading

Frequently Asked Questions